Invention Grant
US08048893B2 Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them
失效
吡唑基衍生物,该方法的制备方法和中间体作为药物产品和含有它们的药物组合物
- Patent Title: Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them
- Patent Title (中): 吡唑基衍生物,该方法的制备方法和中间体作为药物产品和含有它们的药物组合物
-
Application No.: US12394589Application Date: 2009-02-27
-
Publication No.: US08048893B2Publication Date: 2011-11-01
- Inventor: Arielle Genevois-Borella , Jean-Luc Malleron , Jean Bouquerel , Gilles Doerflinger , Andrees Bohme , Gaetan Touyer , Jean-Francois Sabuco , Corrine Terrier , Serge Mignani , Michel Evers , Youssef El-Ahmad
- Applicant: Arielle Genevois-Borella , Jean-Luc Malleron , Jean Bouquerel , Gilles Doerflinger , Andrees Bohme , Gaetan Touyer , Jean-Francois Sabuco , Corrine Terrier , Serge Mignani , Michel Evers , Youssef El-Ahmad
- Applicant Address: FR Antony
- Assignee: Aventis Pharma SA
- Current Assignee: Aventis Pharma SA
- Current Assignee Address: FR Antony
- Agent Kelly L. Bender
- Priority: FR0313775 20031125
- Main IPC: A61K31/439
- IPC: A61K31/439 ; A61K31/4155 ; C07D231/20 ; C07D453/02

Abstract:
The present invention relates to the novel derivatives of formula (I) in which A is, if it is present, a (C1-C6) alkyl, a (C3-C6) alkenyl, a (C3-C6) alkynyl, a (C3-C7) cycloalkyl or a (C5-C7) cycloalkenyl, R1 is an NR6R7, (C4-C7) azacycloalkyl, (C5-C7) azacycloalkenyl, (C5-C9) azabicycloalkyl or (C5-C9) azabicycloalkenyl group; A-R1 is such that the nitrogen of R1 and the nitrogen in the 1-position of the pyrazole are necessarily separated by at least two carbon atoms, R3 is an H, halogen, OH, SH, NH2, ORc, SRc, SORa, SO2Ra, NHCHO, NRaRb, NHC(O)Ra, NHC(S)Ra or NHSO2Ra, R4 is an aryl or heteroaryl; and R5 is an H, halogen, CF3, CHF2, CH2F, linear or branched (C1-C6) alkyl or (C3-C7) cycloalkyl, to their racemates, enantiomers and diastereoisomers and to their mixtures, their tautomers and to their pharmaceutically acceptable salts.
Public/Granted literature
Information query
IPC分类: